Dermabrasion for Scarring
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether dermabrasion, a technique that gently removes the top layer of skin, can improve the appearance of scars after Mohs Micrographic Surgery, a common treatment for skin cancer. The researchers aim to determine if this method enhances scar appearance post-healing. They will treat different sides of the wound to identify the most effective approach. This trial suits individuals scheduled for facial or neck surgery with a scar expected to exceed 4 centimeters and who can attend follow-up visits. As an unphased trial, it offers a unique opportunity to contribute to the understanding of scar improvement techniques.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the dermabrasion technique is safe for improving scar appearance?
Research has shown that dermabrasion is generally safe, though some risks exist. This procedure improves the appearance of scars and other skin issues. Studies indicate that while it can smooth the skin, common side effects include discomfort, swelling, redness, and bruising. Some individuals also notice changes in skin color, especially if exposed to the sun soon after the procedure.
Most people tolerate dermabrasion well despite these potential side effects. However, protecting the skin from the sun after treatment is crucial to prevent long-lasting changes in skin color. Overall, dermabrasion is considered safe for many, but awareness of these possible effects is important.12345Why are researchers excited about this trial?
Researchers are excited about dermabrasion for scarring because it offers a unique approach to improving skin appearance by physically removing the top layers of skin. Unlike typical treatments like laser therapy or chemical peels, which use light or chemicals, dermabrasion works by sanding the skin, which can be more precise and controlled. This technique allows for a targeted approach to smoothing out scars, potentially leading to more consistent and noticeable improvements in skin texture. Additionally, it can be particularly effective for certain types of scars that may not respond well to other methods.
What evidence suggests that dermabrasion is effective for improving scar appearance after Mohs Micrographic Surgery?
Research has shown that dermabrasion can effectively improve the appearance of scars. In one study, 80% of patients noticed better-looking scars after six months of treatment. Another review identified dermabrasion as the best method for smoothing out scars. For acne scars, dermabrasion typically results in about a 50% improvement. Overall, evidence supports that dermabrasion can enhance the appearance of scars, though the degree of improvement can vary. Participants in this trial will receive dermabrasion on either the superior or inferior side of their wound to assess its effectiveness.36789
Who Is on the Research Team?
Gloria Xu, MD, PhD
Principal Investigator
UW School of Medicine and Public Health
Are You a Good Fit for This Trial?
This trial is for individuals with scars from Mohs Micrographic Surgery, a skin cancer removal procedure. Participants should be willing to undergo dermabrasion on their scar and follow up for 6 months. Specific eligibility details are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo intraoperative dermabrasion during Mohs Micrographic Surgery
Follow-up
Participants are monitored for scar assessment using POSAS at 3 months post-surgery
Extended Follow-up
Participants may be monitored for additional scar assessment and complications up to 6 months
What Are the Treatments Tested in This Trial?
Interventions
- Dermabrasion
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor